Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
Clinical trial NCT00672191 · COMPLETED
Trial details
- NCT number
- NCT00672191
- Sponsor
- Argos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-08-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.